Searching for how to mix 10mg semaglutide with bac water? Read this first

Picture the situation: a vial, a syringe, and a video that makes it look simple

You've probably come across content online (forums, social-media clips, peptide-supplier guides) showing someone drawing up a syringe from a small glass vial labelled "semaglutide 10mg" and mixing it with bacteriostatic water. The process looks clinical enough. The numbers seem specific. And if you've been priced out of, or turned away from, conventional weight-loss treatment, it's understandable that this route would catch your eye.

Here is the thing those videos almost never say: what they are demonstrating is the reconstitution of a compounded or research-grade peptide that has not been assessed, approved or licensed by the MHRA for use in humans in the UK. That is not a bureaucratic footnote. It is the difference between a medicine that has been through rigorous clinical testing and something that has not. The purity of the powder, the sterility of the vial, the concentration of the finished solution, none of these are independently verified when you buy from an unlicensed source.

There is also a practical maths problem. Getting the bacteriostatic water volume right for a 10mg vial requires precise calculation; a small error produces a solution that is two or three times stronger or weaker than intended. Semaglutide is potent. The dose range for licensed Wegovy starts at 0.25mg and builds slowly over months, fractions of a milligram at a time. Getting that arithmetic wrong at home, with an unlicensed product, is a real risk.

What "10mg semaglutide" tells you about the product you're looking at

Licensed Wegovy pens do not come in a 10mg format. The 10mg semaglutide label is characteristic of compounded or peptide-research vials, sized for bulk reconstitution rather than individual clinical dosing. Legitimate UK prescriptions for semaglutide are dispensed in the doses and pen formats listed in the MHRA-approved Summary of Product Characteristics, 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg, and now up to 7.2mg pens following the MHRA's approval of the higher-dose single pen in April 2026.

The peptide-market context around 10mg semaglutide is worth understanding clearly. These vials are typically sold by research-chemical suppliers under the cover of "not for human use" disclaimers, a legal workaround that does nothing to protect the person who ends up injecting the contents. The MHRA has taken enforcement action against sellers of unlicensed injectable semaglutide products, and its public guidance is unambiguous: buying weight-loss injections from unregistered sources puts you at risk of receiving fake, contaminated or incorrectly dosed products. You can report suspect sellers directly through the MHRA's Yellow Card scheme.

One misconception worth clearing up gently: some people assume that compounded semaglutide is simply a cheaper version of the same thing. It isn't. Even if the active ingredient were identical in purity, the absence of regulated manufacturing standards, sterility testing and dose accuracy means it is a categorically different product, not a bargain, but a gamble.

How licensed semaglutide is actually dispensed in the UK

When semaglutide is prescribed for weight management through a legitimate UK route, the process looks nothing like a peptide reconstitution guide. Wegovy arrives as a pre-filled KwikPen from Novo Nordisk, manufactured under the same regulatory controls that govern any licensed medicine. The dose is pre-set. The needle is attached according to the instruction leaflet. There is no powder, no diluent, no calculation. The NHS semaglutide medicines page explains the pen-use steps clearly, and anyone prescribed Wegovy receives the Patient Information Leaflet with the pen itself.

An oral option also now exists. The MHRA approved Wegovy tablets in June 2026, the UK became the first country in Europe to licence an oral GLP-1 medicine for weight management. The tablet schedule is entirely different from the injection and involves no reconstitution either; it is taken once daily, first thing in the morning, well before food. If you're weighing up which form suits you, that is a conversation for a prescriber who knows your full picture, not something to resolve by reading a dosage chart alone.

If cost is part of why unlicensed options seem appealing, the treatment options at nume include a free consultation with a GPhC-registered Independent Prescriber, transparent pricing with no hidden fees, and free next-working-day delivery, so you can see exactly what a legal, supervised route costs before committing to anything. For context on how private semaglutide pricing works across the UK market, the Wegovy overview page covers what's involved.

What to do if you want semaglutide for weight loss in the UK

The legal route is a prescription following a clinical assessment. A prescriber (a real person, not an automated questionnaire) reviews your BMI, health history, current medicines and suitability before any prescription is issued. At nume, that review happens the same day as your consultation, carried out by a named GPhC-registered prescriber. You can check our pharmacy on the GPhC register (registration number 9012878) and verify any online pharmacy you're considering the same way.

If you've already been researching lower-strength reconstitution guides as well, the same principles apply: the licensed UK medicine does not require mixing at any dose. Our frequently asked questions cover the most common things people want to know before starting, and our clinical team is available seven days a week for aftercare once treatment begins. If you want to explore whether you're a candidate, speaking to our prescribers is the right place to start.